Roche’s High-Stakes Gambit For Genentech
This article was originally published in The Pink Sheet Daily
Executive Summary
In a risky attempt to bring Genentech to the negotiating table, Roche appeals directly to shareholders with a lower offer for the flagship biotechnology company.